STOCK TITAN

Neogen (NEOG) insider: RSU vesting of 38,759; shares 363,081

Filing Impact
(High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Neogen Corp (NEOG) insider filing: An officer (Former CEO) reported RSU vesting and related share movements. On October 27, 2025, 38,759 restricted stock units vested and were settled into an equal number of common shares at $6.19 per share (code M). A separate transaction disposed of 8,527 shares at $6.19 (code F).

Following these transactions, the reporting person beneficially owned 363,081 shares, held directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ADENT JOHN EDWARD

(Last) (First) (Middle)
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Former CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/27/2025 M 38,759 A $6.19 371,608 D
Common Stock 10/27/2025 F 8,527 D $6.19 363,081 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $6.19 10/27/2025 M 38,759 10/27/2025 10/27/2025 Common Stock 38,759 $6.19 38,759 D
Explanation of Responses:
Remarks:
Each RSU is the economic equivalent of one share of common stock. On October 27, 2025, these RSUs vested and were settled for an equal number of shares of common stock.
Christopher Sefcheck (Attorney in Fact) 10/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NEOG report in this Form 4?

An officer (Former CEO) reported the vesting of 38,759 RSUs into common stock and a disposal of 8,527 shares on 10/27/2025.

How many RSUs vested for NEOG on 10/27/2025?

38,759 restricted stock units vested and were settled into an equal number of common shares.

What were the Form 4 transaction codes for NEOG?

Code M for the RSU settlement into shares and code F for the share disposal.

At what price were the NEOG transactions recorded?

Both transactions list a price of $6.19 per share.

What is the reporting person’s ownership after the transactions?

Beneficial ownership is 363,081 common shares, held directly.

What is the reporter’s relationship to NEOG?

The reporting person is an Officer with the title Former CEO.

Which date marks the earliest transaction in this Form 4?

The earliest transaction date is 10/27/2025.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.55B
215.36M
0.85%
112.78%
8.46%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING